Takarazuka, Japan

Shinzi Ueda

This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Chemical Company, Limited. Active years: 1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinzi Ueda. Retrieved from https://idiyas.com/inventor/shinzi-ueda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shinzi Ueda

Introduction

Shinzi Ueda is a notable inventor based in Takarazuka, Japan. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. His work has led to the creation of innovative solutions that enhance the efficacy of medications.

Latest Patents

One of Ueda's most recognized patents is for the invention titled "Dimethyl sulfoxide adducts of penicillins - Sodium 6-[D(-)-.alpha.-(4-hydroxy-1,5-naphthyridine-3-carboxamido)phenylacetamido]penicillanate or its hydroxylated derivative at the p-position of the phenyl group in a crude state can be purified efficiently through its dimethyl sulfoxide adduct." This patent showcases his expertise in pharmaceutical chemistry and his ability to innovate within the field. Ueda holds 1 patent.

Career Highlights

Shinzi Ueda is currently employed at Sumitomo Chemical Company, Limited, where he continues to work on groundbreaking projects. His career has been marked by a commitment to advancing chemical research and developing new applications for existing compounds.

Collaborations

Ueda has collaborated with esteemed colleagues such as Norihiko Tanno and Takashi Harimoto. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Shinzi Ueda's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…